Patent ID: 7649017

Claim:
A method for the treatment of Charcot-Marie-Tooth disease comprising administering to a subject affected by or presenting a risk of developing such disease, a composition consisting essentially of a therapeutically effective amount of at least one therapeutically active ingredient selected from the group consisting of ascorbic acid, ascorbyl palmitate, dipalmitate L-ascorbate, a glycosylated ascorbic acid, a mannosylated ascorbic acid, a fructosylated ascorbic acid, a fucosylated ascorbic acid, a galactosylated ascorbic acid, a N-acetylglucosaminated ascorbic acid, a N-acetylmuramic ascorbic acid, a metal salt of phosphorylated ascorbic acid, an alkaline metal ascorbyl phosphate, an alkaline earth metal ascorbyl phosphate, a transition metal ascorbyl phosphate, an ascorbyl sulphate, ascorbyl-2 glucoside, 2-O-alpha-D-glucopyranosyl ascorbic acid, 6-O-beta-D-galactopyranosyl L-ascorbic acid, and magnesium ascorbyl phosphate.